CME Group Inc (NASDAQ:CME) Declares $0.75 Quarterly Dividend

CME Group Inc (NASDAQ:CME) announced a quarterly dividend on Wednesday, August 7th, RTT News reports. Stockholders of record on Tuesday, September 10th will be given a dividend of 0.75 per share by the financial services provider on Wednesday, September 25th. This represents a $3.00 annualized dividend and a dividend yield of 1.44%.

CME Group has raised its dividend payment by an average of 11.9% per year over the last three years and has raised its dividend every year for the last 8 years. CME Group has a payout ratio of 45.2% meaning its dividend is sufficiently covered by earnings. Analysts expect CME Group to earn $7.33 per share next year, which means the company should continue to be able to cover its $3.00 annual dividend with an expected future payout ratio of 40.9%.

Shares of CME traded up $0.51 during trading hours on Wednesday, hitting $208.89. The stock had a trading volume of 1,674,622 shares, compared to its average volume of 1,634,639. The company’s fifty day moving average price is $201.27. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.04. CME Group has a 52 week low of $161.05 and a 52 week high of $210.17. The stock has a market capitalization of $74.64 billion, a PE ratio of 30.63, a price-to-earnings-growth ratio of 4.58 and a beta of 0.23.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.01. The business had revenue of $1.27 billion for the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm’s quarterly revenue was up 20.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.74 EPS. On average, analysts anticipate that CME Group will post 6.66 EPS for the current fiscal year.

A number of research analysts have issued reports on the stock. Citigroup set a $202.00 target price on shares of CME Group and gave the company a “buy” rating in a research report on Thursday, May 2nd. Rosenblatt Securities downgraded shares of CME Group from a “neutral” rating to a “sell” rating in a research report on Thursday, April 18th. UBS Group upped their target price on shares of CME Group from $190.00 to $194.00 and gave the company a “neutral” rating in a research report on Wednesday, July 3rd. BidaskClub downgraded shares of CME Group from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 11th. Finally, Barclays upped their target price on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research report on Thursday, May 23rd. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $192.14.

In other news, insider Kathleen M. Cronin sold 4,960 shares of the firm’s stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $186.69, for a total transaction of $925,982.40. Following the completion of the transaction, the insider now directly owns 49,337 shares of the company’s stock, valued at approximately $9,210,724.53. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Elizabeth A. Cook sold 300 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $204.27, for a total transaction of $61,281.00. Following the transaction, the director now directly owns 20,821 shares of the company’s stock, valued at $4,253,105.67. The disclosure for this sale can be found here. Insiders have sold a total of 78,873 shares of company stock valued at $15,707,799 over the last ninety days. Company insiders own 1.20% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: Why Invest in Dividend Achievers?

Dividend History for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.